Author： Thomas David R. Penney Claire A. Majumder Amrita Walmsley Amanda M.
Publisher： MDPI
E-ISSN： 1422-0067|12|5|3220-3236
ISSN： 1422-0067
Source： International Journal of Molecular Sciences, Vol.12, Iss.5, 2011-05, pp. : 3220-3236
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The science and policy of pharmaceuticals produced and/or delivered by plants has evolved over the past twenty-one years from a backyard remedy to regulated, purified products. After seemingly frozen at Phase I human clinical trials with six orally delivered plant-made vaccines not progressing past this stage over seven years, plant-made pharmaceuticals have made a breakthrough with several purified plant-based products advancing to Phase II trials and beyond. Though fraught with the usual difficulties of pharmaceutical development, pharmaceuticals made by plants have achieved pertinent milestones albeit slowly compared to other pharmaceutical production systems and are now at the cusp of reaching the consumer. Though the current economic climate begs for cautious investment as opposed to trail blazing, it is perhaps a good time to look to the future of plant-made pharmaceutical technology to assist in planning for future developments in order not to slow this technology’s momentum. To encourage continued progress, we highlight the advances made so far by this technology, particularly the change in paradigms, comparing developmental timelines, and summarizing the current status and future possibilities of plant-made pharmaceuticals.
Related content
Implementation of Glycan Remodeling to Plant-Made Therapeutic Antibodies
By Bennett Lindsay D. Yang Qiang Berquist Brian R. Giddens John P. Ren Zhongjie Kommineni Vally Murray Ryan P. White Earl L. Holtz Barry R. Wang Lai-Xi Marcel Sylvain
International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. :
Access to resources
Recommend
Access to resources
Plant‐made pharmaceuticals: from ‘Edible Vaccines’ to Ebola therapeutics
PLANT BIOTECHNOLOGY JOURNAL (ELECTRONIC), Vol. 1467-7644, Iss. 8, 2015-10 ,pp. :
Commercial‐scale biotherapeutics manufacturing facility for plant‐made pharmaceuticals
PLANT BIOTECHNOLOGY JOURNAL (ELECTRONIC), Vol. 1467-7644, Iss. 8, 2015-10 ,pp. :